RWCRF yields 740.74% · PFE yields 6.13%● Live data
📍 RWCRF pulled ahead of the other in Year 1
Combined, RWCRF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RWCRF + PFE for your $10,000?
RIWI Corp. operates as a trend-tracking and prediction technology firm in the United States, Canada, Europe, and internationally. Its patented cloud-based software solution provides global digital intelligence platform to clients seeking real-time citizen sentiment data. The company offers subscription products, such as RIWI compass to gauge the extent of political and geopolitical risks; RIWI Alpha which provides real-time data on consumer demand and purchase signals for electric vehicles and luxury goods; and RIWI high-frequency economic data stream which provides data on consumer intentions, jobs, and personal income in real-time. It also provides data solutions, including RIWI track for custom surveys and continuous trend tracking, measurement, and prediction; RIWI test, a concept, ad, and message testing; RIWI audience to scale online engagement initiatives or platforms; RIWI rapid response, to assess critical situations; and RIWI omnibus to source answers to a few questions using random domain intercept technology. The company serves government and public sector, financial services, healthcare, international development, and consumer service industries. RIWI Corporation was incorporated in 2009 and is headquartered in Toronto, Canada.
Full RWCRF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.